Older person with rheumatoid arthritis (RA) make up an increasing proportion of those treated with biologic disease modifying anti-rheumatic agents (DMARDs). The safety of these agents may differ for this subgroup of older RA patients, yet effects have generally not been selectively studied in this population.
Arthritis News
No Link Between RA Therapy and Lymphoma Observed in Large Cohort of Rheumatoid Arthritis Patients
Individuals with rheumatoid arthritis (RA) are at an increased risk for lymphoma compared to the general population, with the risk increasing in proportion to cumulative exposure to systemic inflammation. Whether RA therapies, such as biologic and non-biologic DMARDs, contribute to this risk is controversial.
Brain Centers Responsible for Emotion and Fear Process OA Pain
Pain perception in osteoarthritis (OA) is complex, with the intensity of pain reported in affected individuals often with little correlation to structural damage. Few studies have explored the neural networks responsible for processing pain in OA.
High rates of continuation for RA patients switched to second TNF inhibitor
A strong association between chondrocalcinosis, resulting from calcium pyrophosphate dihydrate (CPPD) deposition, and knee osteoarthritis (OA) is firmly established. However, despite the association, a causative pathogenic role for CPPD crystals on the progression of articular degeneration in the knee has not been definitively demonstrated.
High rates of continuation for RA patients switched to second TNF inhibitor
[…]
RA Patients in Remission May Still Have Subclinical Synovitis
[…]
